carmustine has been researched along with Pneumonia in 13 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our aim was to describe the incidence, clinical course, and risk factors for idiopathic pneumonia syndrome (IPS) after high-dose chemotherapy with cyclophosphamide, carmustine, and thiotepa followed by autologous stem cell transplantation for high-risk breast cancer." | 3.72 | Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer. ( Champlin, RE; Giralt, SA; Rondon, G; Saliba, RM; Shannon, VR; Ueno, NT; Wong, R, 2003) |
| "Three patients died secondary to pneumonitis-related complications." | 1.38 | Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant. ( Abramson, JS; Armand, P; Brown, JR; Chen, YB; Feng, Y; Fisher, DC; Freedman, AS; Jacobsen, ED; LaCasce, AS; Lane, AA; McAfee, SL; Neuberg, DS; Spitzer, TR, 2012) |
| "A patient who developed pneumonitis immediately after the administration of carmustine (BCNU), within exactly the same field as previous irradiation, is presented." | 1.29 | Recall lung pneumonitis due to carmustine after radiotherapy. ( Agrawal, S; Geddes, DM; Gore, M; Thomas, PS, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, AA | 1 |
| Armand, P | 1 |
| Feng, Y | 1 |
| Neuberg, DS | 1 |
| Abramson, JS | 1 |
| Brown, JR | 1 |
| Fisher, DC | 1 |
| LaCasce, AS | 1 |
| Jacobsen, ED | 1 |
| McAfee, SL | 1 |
| Spitzer, TR | 1 |
| Freedman, AS | 1 |
| Chen, YB | 1 |
| Till, BG | 1 |
| Madtes, DK | 1 |
| Abushamaa, AM | 1 |
| Sporn, TA | 1 |
| Folz, RJ | 1 |
| Wong, R | 1 |
| Rondon, G | 1 |
| Saliba, RM | 1 |
| Shannon, VR | 1 |
| Giralt, SA | 1 |
| Champlin, RE | 1 |
| Ueno, NT | 1 |
| Collis, CH | 1 |
| Applebaum, FR | 1 |
| Meyers, JD | 1 |
| Fefer, A | 1 |
| Fluornoy, N | 1 |
| Cheever, MA | 1 |
| Greenberg, PD | 1 |
| Hackman, R | 1 |
| Thomas, ED | 1 |
| Thomas, PS | 1 |
| Agrawal, S | 1 |
| Gore, M | 1 |
| Geddes, DM | 1 |
| Rubio, C | 1 |
| Hill, ME | 1 |
| Milan, S | 1 |
| O'Brien, ME | 1 |
| Cunningham, D | 1 |
| Schmitz, N | 1 |
| Diehl, V | 1 |
| Green, MR | 1 |
| Hossfeld, DK | 1 |
| Tormey, D | 1 |
| Ellison, RR | 1 |
| Massin, F | 1 |
| Coudert, B | 1 |
| Foucher, P | 1 |
| Lombard, JN | 1 |
| Reybet-Degat, O | 1 |
| Jeannin, L | 1 |
| Camus, P | 1 |
2 reviews available for carmustine and Pneumonia
| Article | Year |
|---|---|
Lung damage from cytotoxic drugs.
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carmustine; Chlorambucil; Cyclophosphamide | 1980 |
[Nitrosourea-induced lung diseases].
Topics: Adult; Brain Neoplasms; Carmustine; Child; Drug Therapy, Combination; Female; Humans; Iatrogenic Dis | 1992 |
11 other studies available for carmustine and Pneumonia
| Article | Year |
|---|---|
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; | 2012 |
BCNU-associated pneumonitis: portrait of a toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Etoposide; Female; Hum | 2012 |
Oxidative stress and inflammation contribute to lung toxicity after a common breast cancer chemotherapy regimen.
Topics: Amifostine; Animals; Antineoplastic Agents, Alkylating; Antioxidants; Blood Cell Count; Body Weight; | 2002 |
Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cyclophosphamid | 2003 |
Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins.
Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Carmustine; Child; Cyclophosphamide; Cy | 1982 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 41-1980.
Topics: Astrocytoma; Carmustine; Cerebellar Neoplasms; Child, Preschool; Diagnosis, Differential; Female; Hu | 1980 |
Recall lung pneumonitis due to carmustine after radiotherapy.
Topics: Antineoplastic Agents, Alkylating; Carmustine; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; P | 1995 |
Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Carmustine; Female; Hodgkin Disease; Humans; M | 1997 |
Carmustine and the lungs .
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Child; Female; Hodgkin Disease; Huma | 1997 |
Pulmonary toxicity in cancer chemotherapy.
Topics: Antineoplastic Agents; Carmustine; Female; Humans; Lung Diseases; Neoplasms; Pneumonia; Prednisone | 1979 |
Ph1-positive megakaryoblastic leukemia.
Topics: Acute Disease; Autoradiography; Blood Cell Count; Blood Platelets; Bone Marrow; Carmustine; Chromoso | 1975 |